financetom
Business
financetom
/
Business
/
Mexican president says did not discuss tariffs in call with Trump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mexican president says did not discuss tariffs in call with Trump
Nov 28, 2024 7:30 AM

MEXICO CITY (Reuters) - Mexico's President Claudia Sheinbaum said on Thursday she did not specifically discuss tariffs in a call with U.S. President-elect Donald Trump a day earlier, after Trump threatened a 25% import tax that appears to contravene a free trade pact.

Sheinbaum told a morning press conference the two discussed the causes for which Trump had threatened tariffs, namely illegal migration and fentanyl trafficking, and that in time they would discuss the flow of U.S. guns to Mexican criminal organizations.

"It was a good conversation and we are going to keep having conversations," Sheinbaum said, adding the two had agreed there would be good relations between the two nations.

Following the call on Wednesday, Trump said Sheinbaum had "agreed to stop migration through Mexico, and into the United States, effectively closing our Southern Border."

Sheinbaum, however, said she had laid out a strategy that "attended to" migrants before they reached the U.S. border. "Mexico's stance is not to close borders, but to build bridges between governments and their peoples," she said in a post on X after Trump's post.

Mexico and the United States are each others' top trade partners.

The Mexican peso strengthened about 1% against the dollar on Thursday.

Earlier on Thursday, Mexican Economy Minister Marcelo Ebrard said in an interview with local media that he did not believe it was likely the U.S. would impose the tariffs proposed by Trump as it would be very costly on both sides of the border.

"It's a shot in the foot," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CompoSecure Shares Rise After Q4 Results Top Estimates
CompoSecure Shares Rise After Q4 Results Top Estimates
Mar 7, 2024
01:44 PM EST, 03/07/2024 (MT Newswires) -- CompoSecure ( CMPO ) shares jumped 30% in recent Thursday trading, a day after the company reported Q4 earnings and revenue that topped estimates by analysts. The company on Wednesday reported Q4 adjusted diluted earnings of $0.26 a share, up from $0.20 a year earlier. Analysts polled by Capital IQ expected $0.23. Revenue...
Albemarle Unusual Options Activity
Albemarle Unusual Options Activity
Mar 7, 2024
Investors with a lot of money to spend have taken a bullish stance on Albemarle . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALB,...
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
Mar 7, 2024
LAGUNA BEACH, California (Reuters) -Rivian on Thursday unveiled its smaller and less expensive R2 SUVs and R3 crossovers amid a slowdown in demand for EVs and also said it would start producing the R2 at its existing facility in Illinois to ensure deliveries in 2026. Rivian shares were up 10% at $12.16 on Thursday afternoon. The R2, with a starting...
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Mar 7, 2024
Thursday, Alligator Bioscience AB and Aptevo Therapeutics Inc ( APVO ) released interim data from the dose escalation phase of their Phase 1 trial evaluating ALG.APV-527 for solid tumors likely to express the tumor antigen 5T4. The multi-center, dose-escalation trial is now more than 50% enrolled, and preliminary results include: Treatment was overall well-tolerated, and a maximum tolerated dose has not yet been determined. Dose...
Copyright 2023-2025 - www.financetom.com All Rights Reserved